Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease

  title={Folic Acid Supplementation for Stroke Prevention in Patients With Cardiovascular Disease},
  author={Tao Tian and Kunqi Yang and Jin-Gang Cui and Lanlan Zhou and Xian-liang Zhou},
  journal={The American Journal of the Medical Sciences},

Figures and Tables from this paper

B vitamins for stroke prevention
  • G. Hankey
  • Medicine, Biology
    Stroke and Vascular Neurology
  • 2018
Evidence from observational genetic epidemiological studies, randomised controlled clinical trials, and evidence from established policies of population folate supplementation is concordant in suggesting an absence of benefit from lowering of homocysteine with folic acid for prevention of stroke.
Effect of Vitamin B6, B9, and B12 Supplementation on Homocysteine Level and Cardiovascular Outcomes in Stroke Patients: A Meta-Analysis of Randomized Controlled Trials
A meta-analysis demonstrated up-to-date evidence on the beneficial effect of vitamin B supplementations in reducing homocysteine and preventing the combined risk of stroke, myocardial infarction, and vascular death among stroke patients.
The current status of homocysteine as a risk factor for cardiovascular disease: a mini review
A focused Medline search of the English language literature was conducted between 2010 and 2017 using the terms, homocysteine, risk factor, atherosclerosis, cardiovascular disease, stroke, treatment, and 38 papers with pertinent information were selected and there is a controversy regarding the significance of homocy steine as a risk factor for CVD and stroke.
Benefits and risks of the treatment with fibrates––a comprehensive summary
Fibrates are performing well as drugs that reduce residual risk in patients with atherogenic dyslipidemia and hypertriglyceridemia, and the adverse events rate is not negligible, but definitely manageable by selection of proper target population and supervision of treated patients.
Dietary Intake of Homocysteine Metabolism-Related B-Vitamins and the Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies
It is found that dietary intake of vitamin B-6 and folate were associated with a reduced risk of stroke, and this inverse association remained significant in studies with >10 y of follow-up periods and among participants without a pre-existing stroke event.
The importance of homocysteine in the development of cardiovascular complications in patients with rheumatoid arthritis
Rheumatoid arthritis (RA) not only leads to disability due to joint changes, but also significantly shortens the life expectancy of patients, mainly due to more frequent occurrence of heart attacks
Overview of Meta-Analyses: The Impact of Lifestyle on Stroke Risk
An overview of meta-analyses that have investigated the impact of different foods and / or drinks in relationship with the risk of stroke events (ischemic/ hemorrhagic) shows that all primary studies came from countries with high income level.
Hyperhomocysteinemia: The independent risk factor of cardiovascular diseases
A review of the research conducted on Hcy provides a framework for the factors associated with Hcy and CVD and finds convincing evidence on link between B vitamin deficiencies and increased CVD risk.


Efficacy of folic acid supplementation in stroke prevention: a meta-analysis
Folic acid supplementation is effective in stroke prevention in populations with no or partial folic acid fortification, and a greater beneficial effect was observed among trials with a lower percent use of statins.
Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention: A Meta-Analysis
Folic acid supplementation did not demonstrate a major effect in averting stroke, however, potential mild benefits in primary stroke prevention, especially when folate is combined with B vitamins and in male patients, merit further investigation.
Effect of B-vitamin Supplementation on Stroke: a Meta-Analysis of Randomized Controlled Trials
This study indicates that B-vitamin supplementation is not associated with a lower risk of stroke based on relative and absolute measures of association.
Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease
B vitamin supplementation for homocysteine reduction significantly reduced stroke events, especially in subjects with certain characteristics who received appropriate intervention measures.
Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
Among adults with hypertension in China without a history of stroke or MI, the combined use of enalapril and folic acid, compared with en alapril alone, significantly reduced the risk of first stroke.
Homocysteine lowering with folic acid and B vitamins in vascular disease.
Supplements combining folic acid and vitamins B6 and B12 did not reduce the risk of major cardiovascular events in patients with vascular disease.
Secondary prevention with folic acid: results of the Goes extension study
The results of an open label intervention study with folic acid in a population with stable coronary artery disease while taking stable statin treatment did not appear to attenuate the risk for recurrent events and longer follow up observations are necessary before definite conclusions can be made.
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial.
After 7.3 years of treatment and follow-up, a combination pill of folic acid, vitamin B6, and vitamin B12 did not reduce a combined end point of total cardiovascular events among high-risk women, despite significant homocysteine lowering.